Whereas ATF6 negatively regulates the expression of CFTR, we showed that its inhibition using siRNA in transfected A549 cells expressing p.Phe508del-CFTR restores the Cl-flux, making ATF6 a potential therapeutic target for CF [29,30,31,32]. Here, ATF6 is linked to cystic fibrosis.